Large Scale Biology Adds Nine Patents to IP Portfolio | GenomeWeb

NEW YORK, Nov. 15 – Large Scale Biology was issued nine new patents the company plans to use in its proteomics, functional genomics, and biomanufacturing operations, the company announced Thursday.

The patents issued to the Vacaville, Calif.-based company include US Patent No 6,254,834 for, according to the company, “distinguishing infectious agents, for identifying known viral pathogens, and for discovering and characterizing unknown viral pathogens.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.